"EMA has now made its validation of the application as a first step and
© Modular Finance, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.918 SEK | +9.03% | +17.99% | -25.37% |
05-03 | Nanexa AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | Nanexa AB Announces Approval of Clinical Trial Application for NEX-22 Study Delayed | CI |
"EMA has now made its validation of the application as a first step and
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-25.37% | 10.56M | |
+0.82% | 213M |